Dr. Douglas Smith provides an update on COVID-19 and vaccination in May 2021. For more information about the Integrated Care @ NEOMED (IC@N) ECHO program, visit https://libraryguides.neomed.edu/ICAN…The information shared during this presentation solely represent the opinions and expertise of the presenter and are not those of Northeast Ohio Medical University unless expressly stated otherwise.
Tag: adverse effect
Food and Drug Interactions – Systems of Care ECHO for Multi-System Youth
Dr. Sara Dugan discusses the mechanisms by which food and medication may interact. By the end of this lecture, you will be able to: 1) describe how food and drugs may interact, 2) list foods and medications that may result in interactions, and 3) identify steps to address food and drug interactions.
Hyperprolactinemia: The medications that can cause it and what can be done about it.
In this lecture, Dr. Dugan discusses medications that commonly cause hyperprolactinemia and presents options for management. By the end of this lecture, you will be able to: 1) list the causes of elevated prolactin levels, 2) identify symptoms associated with elevated prolactin levels, and 3) compare the impact medications commonly used for mental health conditions have on prolactin levels.
Nicotine: Is It Good or Bad for People with Schizophrenia?
In this lecture, Dr. Dugan discusses the impact of nicotine on schizophrenia. By the end of this lecture, you will be able to: 1) describe the actions of nicotine on neurotransmitters, 2) list potential reasons for high use of nicotine products, specifically cigarettes in patients with schizophrenia, and 3) identify evidence of nicotine’s actions in patients with schizophrenia.
Amantadine: Mechanisms of Action and Potential Therapeutic Uses
In this lecture, Dr. Dugan examines some of the potential therapeutic uses for amantadine, explains its mechanisms of action, and reviews potential risks. By the end of this lecture, you will be able to: 1) describe the mechanism of action of amantadine, 2) list the adverse effects associated with the use of amantadine, and 3) identify uses for amantadine in patients with mental health conditions.
MAO Inhibitors. How Do These Antidepressants Work and How to Use Them Safely
In this lecture, Dr. Dugan explains how the MAO inhibitors work and the mechanisms behind the potential risks. She also discusses the therapeutic benefits of these medications and how to use them safely. By the end of this lecture, you will be able to: 1) describe the mechanism of action of the monoamine oxidase inhibitors (MAOIs), 2) identify relevant interactions of MAOIs with medications and foods, and 3) evaluate efficacy data of MAOIs in treatment of depression.
Drug Interactions with Psychiatric Medications
In this lecture, Dr. Dugan covers the basics of drug metabolism and highlights several important psychiatric drug-drug interactions that patients as well as prescribers should be aware of. By the end of this lecture, you will be able to: 1) compare pharmacodynamic and pharmacokinetic drug interactions and 2) identify relevant drug interactions with medications used in the treatment of mental illnesses.
What are the risks of Lithium and How to use it safely?
In this lecture, Dr. Dugan takes a look at the risk profile of lithium and discusses ways to use it safely. By the end of this lecture, you will be able to: 1) list the indications for use of lithium, 2) identify short- and long-term adverse effects associated with lithium use, and 3) compare monitoring recommendations for patients on lithium.
Tricyclic Antidepressants: An Overview
In this lecture, Dr. Dugan discusses the tricyclic antidepressants including their mechanism of action, indications, dosing, monitoring, and common side effects. By the end of this lecture, you will be able to: 1) describe the pharmacology of the tricyclic antidepressants (TCA), 2) identify relevant pharmacokinetic differences between TCAs, and 3) evaluate the literature on TCAs for the treatment of depression.
Addressing Clozapine Associated Sedation
In this lecture, Dr. Dugan looks at the prevalence of clozapine-associated sedation, discusses pharmacological actions of clozapine that may contribute to sedation, and surveys some treatment strategies to reduce or eliminate this side effect. By the end of this lecture, you will be able to: 1) describe the prevalence of clozapine associated sedation, 2) identify pharmacologic actions that may contribute to sedation with clozapine, and 3) evaluate treatment strategies for addressing sedation with clozapine.
